EasyGroup Launches easyDelivery to Unify Europe’s Fragmented Last-Mile Logistics
EasyGroup launches easyDelivery, a pan-European aggregator of delivery and pickup points for e-commerce
EasyGroup launches easyDelivery, a pan-European aggregator of delivery and pickup points for e-commerce
Pleo lays off 50 employees in latest round of cuts
Creator Fund, a UK-based pre-seed venture capital firm, has closed its first European fund at $56 million to back scientific founders in deep tech sectors
Øresund Startups is recruiting ambassadors to represent them at networking events in the Øresund region
Framna published research on mobile app user expectations, finding that users have higher expectations for mobile apps due to AI tools
Grundium, a Finnish Healthtech startup, acquired Visiopharm, a Danish AI-driven precision pathology software provider, to build an end-to-end AI precision pathology platform.
P-Secure, a Copenhagen-based technology company founded in 2022, has announced a €1.8 million funding round to accelerate its expansion across Europe. The capital injection brings the company’s total funding to €4.5 million since its establishment. The round was led by Michael Holm, an experienced entrepreneur known for building and scaling global enterprises. Holm joins existing … Read more
OMHU CPH won three awards at E-handelsprisen 2026, including the Gold Award, Best Export E-Commerce Business, and Best New E-Commerce Business
Atlo, a Copenhagen-based AI-powered wholesale platform, has secured investment from prominent Scandinavian retail-tech entrepreneurs. The platform aims to digitalize wholesale ordering for interior design and lifestyle brands by automating workflows, predicting reorder needs, and providing real-time performance data. Founded by Casper Brix, former Head of Purchasing at AndLight, the platform targets an industry still operating primarily through emails and spreadsheets.
Danish biotech startup Alcolase raised €1.5 million to develop an enzyme-based technology that breaks down alcohol in the stomach before absorption, targeting the 540 million people in East Asia with ALDH2 deficiency (genetic alcohol intolerance). The company plans to launch in Singapore and South Korea, with a UK subsidiary supporting therapeutic drug delivery development.